About
- Home
- About
Nova Biotech Capital
Nova Biotech Capital is an independent advisory focused on facilitating capital access and strategic opportunities within the biotechnology and life sciences sectors.
Our purpose is to connect innovative companies with institutional investors, pharmaceutical partners and strategic stakeholders who are committed to advancing high-impact healthcare solutions.
Through our network and industry insight, we support the development and growth of companies working on innovative therapies, orphan drugs, breakthrough technologies, diagnostics and medical advancements.
We believe that meaningful progress is driven by the combination of scientific innovation, strategic collaboration and access to the right capital.
By bridging the gap between innovation and investment, we help transform potential into progress and contribute to the advancement of global healthcare.
Mission
At Nova Biotech Capital, our mission is to connect innovative biotechnology companies with the capital and strategic partnerships required to advance breakthrough therapies and high-impact healthcare solutions.
We aim to facilitate the development of transformative treatments by bridging the gap between scientific innovation and institutional investment.
Our Impact
We support the growth of companies developing cutting-edge therapies, orphan drugs and breakthrough technologies that address unmet medical needs across a wide range of diseases.
By enabling access to capital and strategic partnerships, we contribute to accelerating innovation within the global life sciences ecosystem.
Our role is to ensure that promising scientific advancements have the resources and connections needed to reach their full potential.
Impact on Patients
Ultimately, our work contributes to improving patient outcomes by supporting the development of more effective treatments, earlier diagnoses and innovative healthcare solutions.
We believe that access to the right capital and partnerships can accelerate the delivery of life-changing therapies to patients worldwide.
Our focus is on enabling progress that leads to meaningful improvements in quality of life and long-term healthcare impact.
Turning Innovation Into Impact
We connect innovative biotechnology companies developing breakthrough therapies, orphan drugs and advanced technologies with strategic investors, expert guidance and global partnerships to accelerate development and create meaningful impact on society.
Why Nova Biotech Capital
Specialized Focus
Nova Biotech Capital works exclusively with biotechnology and life sciences companies, allowing for a deep understanding of the sector’s scientific, financial and strategic dynamics.
International Network
We maintain relationships with investors, pharmaceutical companies and industry partners across the United States, Europe and Asia.
Selective Engagement
We work with a limited number of companies to ensure dedicated attention and alignment throughout each engagement.
Strategic Access
Our role is to facilitate meaningful introductions between biotechnology innovators and the right investors or pharmaceutical partners.
Confidential Approach
All engagements are handled with strict confidentiality and professional discretion.
Start a Confidential Conversation
If you are a biotechnology company seeking capital or strategic partnerships, we invite you to connect with us for a confidential discussion. We are committed to understanding your vision and exploring opportunities to support your growth.
Frequently Asked Questions
We connect biotechnology and life sciences projects with strategic investors, industry partners, and development opportunities to help accelerate research, innovation, and impact.
We support biotechnology and healthcare initiatives across therapeutic areas, including drug development, orphan drugs, breakthrough technologies, diagnostics, medical technology and clinical innovation.
We work with biotechnology companies, research teams, healthcare innovators, institutional investors and strategic partners across the life sciences sector.
Our focus includes companies developing innovative therapies, orphan drugs, breakthrough technologies and other high-impact healthcare solutions.
Yes. We consider both early-stage and growth-stage biotechnology companies, provided they demonstrate strong scientific potential, a clear strategic vision and meaningful relevance within the life sciences sector.
Start a Confidential Conversation
If you are a biotechnology company seeking capital or strategic partnerships, we invite you to connect with us for a confidential discussion. We are committed to understanding your vision and exploring opportunities to support your growth.
OUR TEAM
José Mª Pujol
Founding Partner & CEO
Every Broken
Managing Director
Every Broken
Managing Director
Every Broken
Managing Director
Every Broken
Managing Director